September 1, 2022 – Pritzker Levine is pleased to announce that partner Elizabeth C. Pritzker has been named the 2022 “Antitrust Lawyer of the Year” by the Antitrust and Unfair Competition Law Section of the California Lawyers Association. Elizabeth will […]
Elizabeth C. Pritzker Named the 2022 “Antitrust Lawyer of the Year” Read More »
July 11, 2022 – Judge Daniel D. Crabtree has granted final approval to the $264 million settlement between Plaintiffs and the Mylan Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, finding the settlement to
March 1, 2022 – Plaintiffs in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, have reached a $264 million settlement with the Mylan Defendants to resolve class claims that Mylan, together with the Pfizer Defendants, engaged
Plaintiffs Reach Settlement with the Mylan Defendants in EpiPen Class Action Read More »
November 17, 2021 – Today, Judge Daniel D. Crabtree granted final approval of the settlement between Plaintiffs and the Pfizer Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, proceeding in the United States District
June 21, 2021 – In a ground-breaking, unanimous decision, the United States Supreme Court affirmed Northern District of California Judge Claudia Wilken’s determination following a bench trial that NCAA limits on education-related benefits were unreasonable restraints of trade under antitrust law and